April 23, 2026 The FDA gives the green light to the first gene therapy for deafness The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone. from NPR Topics: News https://ift.tt/TRupIQj
